BRITISH AMERICAN TOBACCO (BATS.L)

Key Updates

BATS.L has declined 2.25% to £4,474 since the July 23 report (£4,577), continuing the pullback from the July 17 peak of £4,673. The move lower is driven by two material developments: H1 2026 results confirming a deepening cigarette volume decline (now guided at -3% vs. prior -2.5%), and a U.S. appeals court ruling reinstating a 12-state class-action lawsuit over Natural American Spirit labelling. Despite these near-term headwinds, BAT reaffirmed full-year guidance of 3–5% revenue growth and 4–6% adjusted profit from operations growth, providing a floor to the investment thesis.

Current Trend

BATS.L remains in positive YTD territory at +6.17% as of 3 August 2026, though momentum has deteriorated markedly since the July 16 surge of +5.8% (which represented the largest single-day gain since February 2024). The stock has since retraced approximately 4.3% from that intraday high, forming a pattern of lower highs since the July 17 peak. Short-term momentum is negative across all measured intervals (1d: -2.10%, 5d: -2.04%, 1m: -3.18%), while the 6-month return of +0.95% indicates the medium-term trend is broadly flat. The YTD gain of +6.17% remains intact but is at risk of further compression if litigation and volume headwinds intensify.

Investment Thesis

The core investment thesis for BATS.L rests on three pillars: (1) the combustibles segment generating durable, high-margin free cash flow despite secular volume decline; (2) disciplined capital redeployment into next-generation reduced-risk products (vapes, nicotine pouches) to capture structural category growth; and (3) a cost rationalisation programme — including a nearly 20% workforce reduction — designed to protect margins and fund the transition. Low-single-digit top-line growth is expected over the long term even as global cigarette consumption contracts at a mid-single-digit annual rate.

Thesis Status

The thesis remains broadly intact but faces incremental stress. The reaffirmation of full-year guidance (3–5% revenue growth, 4–6% adjusted profit from operations growth) is supportive, and H1 revenue of £12.24 billion (+1.4% YoY) is directionally consistent with the growth narrative. However, the downward revision to industry cigarette volume guidance (-3% vs. -2.5% prior) signals the combustibles cash engine is under greater pressure than previously modelled. The reinstated U.S. class-action — now spanning 12 states including California, Florida, New York and Illinois — introduces a non-trivial contingent liability that was not fully priced in the prior thesis. The operating profit decline of 16% in H1 to £4.27 billion is a material negative that warrants monitoring. On balance, the thesis is intact but the risk-adjusted return profile has modestly deteriorated since the July 23 report.

Key Drivers

The following factors are the primary drivers of BATS.L's current price action and forward outlook:

• H1 2026 Results & Guidance Reaffirmation: Revenue grew 1.4% YoY to £12.24 billion in H1, but profit from operations fell 16% to £4.27 billion. Full-year guidance was reaffirmed at the lower end of the medium-term range. Source: Morningstar, 30 Jul 2026
• Deepening Cigarette Volume Decline: BAT now expects global cigarette industry volumes to decline approximately 3% in 2026, worse than the prior 2.5% forecast, compressing the free cash flow base of the combustibles segment. Source: Morningstar, 30 Jul 2026
• U.S. Class-Action Litigation Reinstated: The 10th Circuit Court of Appeals ruled that BAT must face class-action claims from consumers in 12 states alleging Natural American Spirit labels misled buyers. The case is returned to district court for further proceedings, extending litigation uncertainty. Source: Reuters, 29 Jul 2026
• Reduced-Risk Product Investment & Workforce Reduction: BAT is deploying combustibles cash flow into vapes and nicotine pouches while cutting nearly 20% of its workforce to streamline operations and protect margins. Source: Morningstar, 30 Jul 2026
• July 16 Surge & Subsequent Retracement: The ADR (BTI) surged 5.8% on 16 July — the largest single-day gain since February 2024 — lifting BATS.L to £4,673. The stock has since retraced, underscoring the fragility of the rally. Source: Morningstar, 16 Jul 2026

Technical Analysis

BATS.L is trading at £4,474, having failed to hold the £4,577 level established in the July 23 report and now approaching the £4,478 level that acted as a near-term low in the July 9 report. This level represents a key near-term support; a sustained break below it would open the path toward the pre-July-surge range. Resistance is established at £4,577 (July 23 close) and more significantly at £4,673 (July 17 peak). The YTD gain of +6.17% provides a broader context of relative resilience, but the sequence of lower highs since July 17 and negative momentum across all short-term intervals (1d, 5d, 1m) confirm a bearish near-term price structure. The 6-month return of +0.95% suggests the stock is consolidating rather than trending decisively in either direction at the medium-term horizon.

Bull Case

• Full-Year Guidance Reaffirmed: Despite H1 headwinds, BAT maintained its 2026 outlook of 3–5% revenue growth and 4–6% adjusted profit from operations growth, providing earnings visibility and limiting downside risk to consensus estimates. Source: Morningstar, 30 Jul 2026
• Combustibles as a Durable Free Cash Flow Engine: The combustibles segment continues to generate robust free cash flow despite secular volume decline, funding the company's transition into reduced-risk categories — a self-financing growth model with limited external capital dependency. Source: Morningstar, 31 Jul 2026
• Reduced-Risk Product Portfolio Expansion: Investment in vapes and nicotine pouches positions BAT to capture structural growth in next-generation categories as consumers migrate away from combustibles, supporting long-term top-line growth. Source: Morningstar, 30 Jul 2026
• Aggressive Cost Rationalisation: The planned ~20% workforce reduction is expected to structurally lower the operating cost base, supporting margin expansion and partially offsetting the impact of declining combustible volumes. Source: Morningstar, 30 Jul 2026
• YTD Outperformance & Broad Market Presence: BATS.L retains a +6.17% YTD gain and the ADR (BTI) trades 21.05% above its 52-week prior level, reflecting the market's recognition of the company's resilient cash generation across approximately 180 countries. Source: Morningstar, 16 Jul 2026

Bear Case

• Accelerating Cigarette Volume Decline: BAT revised its global cigarette industry volume outlook to -3% for 2026 (from -2.5%), with mid-single-digit annual declines projected structurally, directly eroding the free cash flow base underpinning the entire investment thesis. Source: Morningstar, 30 Jul 2026
• U.S. Class-Action Litigation Reinstated Across 12 States: The 10th Circuit's 2-1 ruling reinstates a broad class action covering California, Florida, New York, Illinois and eight other states over Natural American Spirit labelling claims, creating a material and unquantified contingent liability. A dissenting judge flagged the case as a candidate for Supreme Court review, extending the litigation timeline. Source: Reuters, 29 Jul 2026
• H1 Operating Profit Declined 16% YoY: Profit from operations fell sharply to £4.27 billion in H1 2026, a 16% decline year-over-year, indicating that cost pressures and volume headwinds are already materially impacting earnings quality ahead of any litigation costs. Source: Morningstar, 30 Jul 2026
• Full-Year Guidance at Lower End of Medium-Term Range: While guidance was reaffirmed, BAT explicitly guided at the lower end of its medium-term range, signalling limited upside to consensus and reducing the probability of a positive earnings surprise in H2. Source: Morningstar, 30 Jul 2026
• ADR Trades 15.21% Below All-Time High: BTI remains significantly below its all-time closing high of $73.28 (June 2017), reflecting the structural de-rating of the tobacco sector and limiting the valuation re-rating potential even under a bull scenario. Source: Morningstar, 16 Jul 2026